.@UNODC estimates the market value of fake #antimalarials at over US$400mil in west Africa alone
20 April 2015 World Malaria Day panel discussion with Malaria Consortium, Roll Back Malaria, the Global Fund, PATH and delegates from ACP states.
The issue of drug resistant malaria in the Greater Mekong Subregion is an urgent one. We need to see every case as an emergency and to act quickly. Our most effective drugs are under threat and the only way to address this is to eliminate the disease.
Charles Nelson, Chief Executive of Malaria Consortium
On the occasion of World Malaria Day 2015 (25th April), Fight the Fakes partners Malaria Consortium and the Roll Back Malaria Partnership, in partnership with PATH Malaria Vaccine Initiative, hosted a panel discussion on the issue of rising malaria resistance and the potential role the European Union can play in malaria elimination. The event was held at the Africa Caribbean Secretariat in Brussels.
The panel featured Charles Nelson, Chief Executive of Malaria Consortium, Pru Smith, Communications Adviser of Roll Back Malaria Partnership, Walter Seidel, Head of Sector of Health, DG International Cooperation & Development, Scott Filler, Senior Disease Coordinator for Malaria at the Global Fund and Ashley Birkett, Director of the PATH Malaria Vaccine Initiative.
Fake medicines are a contributing factor to the rising rates of antimalarial resistance. As such, the Fight the Fakes campaign is very excited to be a part of increased efforts in malaria elimination. To learn more and help increase awareness around the cause—follow the conversation on Twitter using #DefeatMalaria!
For more information on the event, see here.
For an infographic that shows how fake medicines impact malaria, see here.